Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Neupro"

13:11 EDT 30th July 2014 | BioPortfolio

Original Source: Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PL...

Matching Channels

None

Matching News

Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 62-page report is...

Restless Legs Syndrome - Pipeline Review, H1 2014

Recently added to the BioPortfolio report store, Restless Legs Syndrome - Pipeline Review, H1 2014 is a new report from Global Markets Direct published on 2014-05-14. This 56-page report is available...

PharmaPoint: Parkinson’s Disease - US Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - US Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 209-pa...

UCB announces next chief executive

UCB has revealed that its next chief executive will be Jean-Christophe Tellier, the firm's current head of Biopharma Brands and Solutions.Current chief executive Roch Doliveux is to hand over to Telli...

PharmaPoint: Parkinson’s Disease - Brazil Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - Brazil Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 16...

PharmaPoint: Parkinson’s Disease - Japan Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - Japan Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 170...

PharmaPoint: Parkinson’s Disease - 5EU Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - 5EU Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 249-p...

Parkinson's Disease: World Drug Industry and Market 2014-2024

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Parkinson's Disease: World Drug Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement